Your browser doesn't support javascript.
loading
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Butt, Jawad H; Jhund, Pardeep S; Belohlávek, Jan; de Boer, Rudolf A; Chiang, Chern-En; Desai, Akshai S; Drozdz, Jaroslaw; Hernandez, Adrian F; Inzucchi, Silvio E; Katova, Tzvetana; Kitakaze, Masafumi; Kosiborod, Mikhail N; Lam, Carolyn S P; Maria Langkilde, Anna; Lindholm, Daniel; Bachus, Erasmus; Martinez, Felipe; Merkely, Béla; Petersson, Magnus; Saraiva, Jose F Kerr; Shah, Sanjiv J; Vaduganathan, Muthiah; Vardeny, Orly; Wilderäng, Ulrica; Claggett, Brian L; Solomon, Scott D; McMurray, John J V.
Affiliation
  • Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (J.H.B., P.S.J., J.J.V.M.).
  • Jhund PS; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Denmark (J.H.B.).
  • Belohlávek J; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (J.H.B., P.S.J., J.J.V.M.).
  • de Boer RA; Second Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.).
  • Chiang CE; Erasmus Medical Center, Rotterdam, the Netherlands (R.A.d.B.).
  • Desai AS; General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taiwan (C.-E.C.).
  • Drozdz J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D.).
  • Hernandez AF; Department of Cardiology, Medical University of Lodz, Poland (J.D.).
  • Inzucchi SE; Duke University Medical Center, Durham, NC (A.F.H.).
  • Katova T; Yale School of Medicine, New Haven, CT (S.E.I.).
  • Kitakaze M; Department of Noninvasive Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.).
  • Kosiborod MN; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.).
  • Lam CSP; Saint Luke's Mid America Heart Institute, Kansas City, MO (M.N.K.).
  • Maria Langkilde A; National Heart Centre Singapore and Duke National University of Singapore (C.S.P.L.).
  • Lindholm D; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.).
  • Bachus E; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.).
  • Martinez F; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.).
  • Merkely B; University of Cordoba, Argentina (F.M.).
  • Petersson M; Heart and Vascular Centre, Semmelweis University, Budapest, Hungary (B.M.).
  • Saraiva JFK; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.).
  • Shah SJ; Cardiovascular Division, Instituto de Pesquisa Clínica de Campinas, Brazil (J.F.K.S.).
  • Vaduganathan M; Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).
  • Vardeny O; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.C.C., S.D.S.).
  • Wilderäng U; Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota (O.V.).
  • Claggett BL; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.).
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.C.C., S.D.S.).
  • McMurray JJV; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.C.C., S.D.S.).
Circulation ; 146(16): 1210-1224, 2022 10 18.
Article in En | MEDLINE | ID: mdl-36029465

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzhydryl Compounds / Frailty / Glucosides / Heart Failure Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circulation Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzhydryl Compounds / Frailty / Glucosides / Heart Failure Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circulation Year: 2022 Type: Article